OSPERZO 500 mg, granules with extended release 50 sachets of 0.913 g
Active ingredients: Mesalazine
Commercialized according to BDPMDispensing in France: Prescription only
Granules with extended release50 sachets of 0.913 gorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- OSPERZO 500 mg, granulés à libération prolongée
- Pharmaceutical form
- granulés à libération prolongée
- Route of administration
- orale
- Presentation description
- 50 sachet(s) polyester aluminium polyéthylène de 0,913 g de granulés
- Marketing authorisation holder
- FALK PHARMA
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 12 Nov 2025
- Prescription and dispensing conditions
- Prescription only
- List II: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
65580615CIP73026461CIP133400930264614Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| MÉSALAZINEgranulés | 500 mg · un sachet | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.